Mechanistic studies are required to elucidate the biological perturbation that leads to higher BP with the common MTHFR C677T polymorphism and to understand how riboflavin can rescue this phenotype and thus potentially protect against the development of hypertension. This evidence concerns the gene MTHFR and hypertensive disorder.